Browsing by Author "Noort, WA"
Now showing items 1-5 of 5
-
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches
Antonelli, A; Noort, WA; Jaques, J; de Boer, B; de Jong-Korlaar, R; Brouwers-Vos, AZ; Lubbers-Aalders, L; van Velzen, JF; Bloem, AC; Yuan, H (American Society of Hematology, 2016-12-22)To begin to understand the mechanisms that regulate self-renewal, differentiation, and transformation of human hematopoietic stem cells or to evaluate the efficacy of novel treatment modalities, stem cells need to be ... -
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches
Antonelli, A; Noort, WA; Jaques, J; de Boer, B; de Jong-Korlaar, R; Brouwers-Vos, AZ; Lubbers-Aalders, L; van Velzen, JF; Bloem, AC; Yuan, H (2016-12-22) -
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches.
Antonelli, A; Noort, WA; Jaques, J; de Boer, B; de Jong-Korlaar, R; Brouwers-Vos, AZ; Lubbers-Aalders, L; van Velzen, JF; Bloem, AC; Yuan, H (2016-10-12)To begin to understand the mechanisms that regulate self-renewal, differentiation, and transformation of human hematopoietic stem cells or to evaluate the efficacy of novel treatment modalities, stem cells need to be studied ... -
Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
Drent, E; Groen, RWJ; Noort, WA; Themeli, M; van Bueren, JJL; Parren, PWHI; Kuball, J; Sebestyen, Z; Yuan, H; de Bruijn, J (2016-05) -
Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance.
de Haart, SJ; Holthof, L; Noort, WA; Minnema, MC; Emmelot, ME; Aarts-Riemens, T; Doshi, P; Sasser, K; Yuan, H; de Bruijn, J (2016-08)